Brexit negotiators must seek “closest possible regulatory alignment” to protect patients and industry

MPs have called on UK and EU negotiators involved in Brexit talks to protect patient safety by ensuring regulatory alignment and ongoing collaboration in clinical trials.

In a report published on 21 March the parliamentary health and social care committee emphasised the need to maintain patient safety on various fronts.1 MPs on the committee said that Brexit would affect many aspects of health, social care, and the life sciences sector both in the UK and the EU and that, to minimise harm to citizens, both sides had to secure the closest possible regulatory alignment as a priority in the next round of negotiations.

The …